Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2005 (Vol. 25, No. 7)

Amersham Biosciences - Chromatography

URL:www.chromatography.amershambiosciences.com/aptrix/upp00919.nsf/content/labsep_homepage
  • Educational content
  • Not very deep
I always get in a philosophical debate with myself (at least the conversations are fun) about when to carry mostly commercial Websites in the column. I get a lot of requests from suppliers to mention their sites here, but most of them never make it because they don’t really have anything to offer readers other than an online commercial for their materials. My guideline is that any site I cover has to have meaningful information, ideally available for free. That said, the Amersham site makes its appearance thanks to its Education and Purification Centers which provide visitors with general educational content on topics such as developing purification protocols, affinity chromatography, and a protein purifier tutorial. I’m disappointed that the descriptions are not “deeper,” but as a whole, this site is worth a quick look.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »